Filtered By:
Drug: Dexamethasone
Countries: Germany Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 28 results found since Jan 2013.
Production and certification of BOTS-1: bovine muscle-certified reference material for incurred veterinary drug residues
Anal Bioanal Chem. 2023 Jun 16. doi: 10.1007/s00216-023-04794-5. Online ahead of print.ABSTRACTA freeze-dried bovine muscle-certified reference material (CRM), known as BOTS-1 (DOI: https://doi.org/10.4224/crm.2018.bots-1 ), containing incurred residues of commonly used veterinary drugs was produced and certified for the mass fraction of eight veterinary drug residues. Value assignment was carried out using liquid chromatography tandem mass spectrometry (LC-MS/MS) methods in conjunction with isotope dilution and standard addition approaches involving stable isotope internal standards. Data from the National Research Counci...
Source: Analytical and Bioanalytical Chemistry - June 16, 2023 Category: Chemistry Authors: Garnet McRae Donald M Leek Juris Meija Bryn Shurmer Steven J Lehotay Joachim Polzer Jeremy E Melanson Zoltan Mester Source Type: research
Whom should we screen for Cushing's syndrome: The Endocrine Society Practice Guideline Recommendations 2008 revisited
CONCLUSIONS: The 2008 Endocrine Society Practice guideline for screening and diagnosis of CS defined at-risk populations that should undergo testing. These recommendations are still valid in 2022.PMID:35730067 | DOI:10.1210/clinem/dgac379
Source: The Journal of Clinical Endocrinology and Metabolism - June 22, 2022 Category: Endocrinology Authors: Leah T Braun Frederick Vogel Stephanie Zopp Thomas Marchant Seiter German Rubinstein Christina M Berr Heike K ünzel Felix Beuschlein Martin Reincke Source Type: research
Treatment of diabetic macular edema with intravitreal DEX Implant in Germany: Efficacy and safety in na ïve and pre-treated patients in clinical practice
CONCLUSION: After treatment with DEX implant, BCVA increased and CRT decreased significantly in the whole population at all time points. No significant differences were found between naïve and pre-treated patients. Changes in BCVA and CRT in the naïve group were not statistically significant. This was most likely attributable to the small sample size. The data underlines the importance of DEX implant as an efficacious and safe alternative to VEGF- inhibitors in real world practice.PMID:35345914 | DOI:10.1177/11206721221076697
Source: European Journal of Ophthalmology - March 29, 2022 Category: Opthalmology Authors: Albert Joseph Augustin Source Type: research
The Prevention and Treatment of Nausea and Vomiting During Tumor Therapy
CONCLUSION: Detailed, effective, risk profile-adapted algorithms for the prevention and treatment of nausea and vomiting are now available for patients undergoing classic chemotherapy regimens or combined radiotherapy and chemotherapy. Optimal symptom control for patients undergoing oral tumor therapy over multiple days in the outpatient setting remains a challenge.PMID:35140010 | DOI:10.3238/arztebl.m2022.0093
Source: Deutsches Arzteblatt International - February 10, 2022 Category: General Medicine Authors: Franziska Jahn Bernhard W örmann Juliane Brandt Annette Freidank Petra Feyer Karin Jordan Source Type: research
